SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-525912
Filing Date
2016-03-31
Accepted
2016-03-31 16:37:37
Documents
23
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d141032d20f.htm 20-F 1330507
2 EX-8.1 d141032dex81.htm EX-8.1 3154
3 EX-12.1 d141032dex121.htm EX-12.1 6339
4 EX-12.2 d141032dex122.htm EX-12.2 6330
5 EX-13.1 d141032dex131.htm EX-13.1 4464
6 EX-15.1 d141032dex151.htm EX-15.1 1498
7 GRAPHIC g141032page042.jpg GRAPHIC 98593
8 GRAPHIC g141032page043.jpg GRAPHIC 50085
9 GRAPHIC g141032page044.jpg GRAPHIC 7681
10 GRAPHIC g141032page046a.jpg GRAPHIC 21947
11 GRAPHIC g141032page046b.jpg GRAPHIC 77820
12 GRAPHIC g141032page047.jpg GRAPHIC 19603
13 GRAPHIC g141032page049.jpg GRAPHIC 30633
14 GRAPHIC g141032page050.jpg GRAPHIC 78856
15 GRAPHIC g141032page051a.jpg GRAPHIC 18910
16 GRAPHIC g141032page051b.jpg GRAPHIC 59551
17 GRAPHIC g141032page053a.jpg GRAPHIC 20673
18 GRAPHIC g141032page053b.jpg GRAPHIC 71955
19 GRAPHIC g141032page055.jpg GRAPHIC 129010
20 GRAPHIC g141032page50b.jpg GRAPHIC 26709
21 GRAPHIC g141032page52.jpg GRAPHIC 37558
22 GRAPHIC g141032page54a.jpg GRAPHIC 21327
23 GRAPHIC g141032page54b.jpg GRAPHIC 22430
  Complete submission text file 0001193125-16-525912.txt   2448463
Mailing Address DARWINWEG 24 LEIDEN P7 2333CR
Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36622 | Film No.: 161543702
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences